Rik Wehbring is a Managing Director at Bioeconomy Capital, an early-stage venture capital firm he co-founded in 2014 with Rob Carlson. See contact routes.
Rik Wehbring is a Managing Director at Bioeconomy Capital, an early-stage venture capital firm he co-founded in 2014 with Rob Carlson to accelerate the biotechnology revolution [3]. He brings over 20 years of technical and operational experience from Silicon Valley, including being a co-founder of one of the first “garage biology” startups and running the strategic consulting firm Biodesic [4]. The firm’s investment thesis targets seed and Series A companies in biotechnology, synthetic biology, and advanced bio-manufacturing infrastructure, with a primary focus on the U.S. and occasional investments in the U.K. and other regions [3][7]. Bioeconomy Capital typically invests between $100,000 and $5 million per deal, with a sweet spot of $1.5 million, and often acts as a lead investor to help portfolio companies scale [7]. Notable portfolio companies include Planetary Technologies (formerly a Bioeconomy Capital investment), The Nuclear Company (which received a $46 million Series A in May 2025), and Cyclic Materials, though specific attribution of Wehbring’s personal involvement in each is not detailed in available sources [1][3][4]. Wehbring has publicly stated that Bioeconomy Capita
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Seattle.
Investors like Rik Wehbring · Full investor directory · Investor access · Company funding database